Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
SAGE Therapeutics (SAGE)
NASDAQ:SAGE
Holding SAGE?
Track your performance easily
See the Price Targets and Ratings of:
SAGE Analyst Ratings
Hold
1 Buy
14 Hold
2 Sell
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months
SAGE Stock 12 Month Forecast
Average Price Target
$10.92
▲(36.33% Upside)
| Highest Price Target$25.00 | Average Price Target$10.92 | Lowest Price Target$4.00 |
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.
Detailed List of Analyst Forecasts
Ranks
Any
Analyst Rating
Any
Upside/ Downside
Any
Action
Any
TD Cowen
Assigned
10/21/24
Scotiabank
Reiterated
10/18/24
Needham
Reiterated
10/17/24
Raymond James
Initiated
10/10/24
H.C. Wainwright
Reiterated
10/09/24
Robert W. Baird
Assigned
10/08/24
Stifel Nicolaus
Reiterated
10/08/24
Bank of America Securities
Reiterated
10/08/24
RBC Capital
Downgraded
10/04/24
Truist Financial
Reiterated
08/14/24
Canaccord Genuity
$17→$9
Hold
12.36%
Upside
Reiterated
08/06/24
Sage Therapeutics (SAGE) PT Lowered to $9 at Canaccord GenuityCanaccord Genuity analyst Sumant Kulkarni lowered the price target on Sage Therapeutics (NASDAQ: SAGE) to $9.00 (from $17.00) while maintaining a Hold rating.
Morgan Stanley
$11
Hold
37.33%
Upside
Reiterated
08/02/24
Morgan Stanley Keeps Their Hold Rating on SAGE Therapeutics (SAGE)
Oppenheimer
$17→$10
Hold
24.84%
Upside
Reiterated
08/01/24
Oppenheimer Reaffirms Their Hold Rating on SAGE Therapeutics (SAGE)
Mizuho Securities
―
Hold
―
Reiterated
08/01/24
Analysts Offer Insights on Healthcare Companies: Teladoc (NYSE: TDOC), SAGE Therapeutics (NASDAQ: SAGE) and Agios Pharma (NASDAQ: AGIO)
Best Analysts Covering SAGE Therapeutics
Which Analyst Should I Follow If I Want to Buy SAGE and Sell After:
1 Month
xxx
Success Rate
8/14 ratings generated profit
Average Return
-2.62%
downgraded a xxx
rating last month
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 1 Month would result in 57.14% of your transactions generating a profit, with an average return of -2.62% per trade.
3 Months
xxx
Success Rate
10/14 ratings generated profit
Average Return
+12.66%
downgraded a xxx
rating last month
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 3 Months would result in 71.43% of your transactions generating a profit, with an average return of +12.66% per trade.
1 Year
Success Rate
9/14 ratings generated profit
Average Return
+38.81%
downgraded a sell rating last month
Copying Brian Abrahams's trades and holding each position for 1 Year would result in 64.29% of your transactions generating a profit, with an average return of +38.81% per trade.
2 Years
xxx
Success Rate
9/14 ratings generated profit
Average Return
+38.81%
downgraded a xxx
rating last month
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 2 Years would result in 64.29% of your transactions generating a profit, with an average return of +38.81% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.
SAGE Analyst Recommendation Trends
Rating
May 24
Jun 24
Jul 24
Aug 24
Oct 24
Strong Buy
3
5
6
6
5
Buy
3
3
1
1
1
Hold
24
29
20
30
32
Sell
4
6
5
3
3
Strong Sell
0
0
0
0
0
total
34
43
32
40
41
Each month's total comprises the sum of three months' worth of ratings.
SAGE Financial Forecast
SAGE Stock Forecast FAQ
What is SAGE’s average 12-month price target, according to analysts?
Based on analyst ratings, SAGE Therapeutics’s 12-month average price target is $10.92.
What is SAGE’s upside potential, based on the analysts’ average price target?
SAGE Therapeutics has 36.33% upside potential, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is SAGE a Buy, Sell or Hold?
SAGE Therapeutics has a consensus rating of Hold which is based on 1 buy ratings, 14 hold ratings and 2 sell ratings.
What is SAGE Therapeutics’s price target?
The average price target for SAGE Therapeutics is $10.92. This is based on 17 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst price target is $25.00 ,the lowest forecast is $4.00. The average price target represents 36.33% Increase from the current price of $8.01.
The highest analyst price target is $25.00 ,the lowest forecast is $4.00. The average price target represents 36.33% Increase from the current price of $8.01.
What do analysts say about SAGE Therapeutics?
SAGE Therapeutics’s analyst rating consensus is a Hold. This is based on the ratings of 17 Wall Streets Analysts.
How can I buy shares of SAGE?
Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.